Other than the original quoted article from Bioworld and Recce announcing that it is targeting the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) global initiative, which is offering a $1 billion reward for each new antibiotic approved, as well as increased R&D funding, I found the following articles and websites that mention these sort of rewards, there is also the Billions of potential revenue for any company that gets a new superbug antibiotic approved.
https://www.washingtonpost.com/opin...ory.html?noredirect=on&utm_term=.d5077c74e22e
http://www.ip-watch.org/2018/02/15/...d-2018-seeks-partners-antibacterial-research/
http://www.cidrap.umn.edu/news-perspective/2018/01/1-billion-reward-proposed-new-antibiotics
https://www.nature.com/articles/ja2017124
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746591/
- Forums
- ASX - By Stock
- Accelerated Approval for RECCE® 327
Other than the original quoted article from Bioworld and Recce...
-
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RCE (ASX) to my watchlist
|
|||||
Last
54.5¢ |
Change
0.035(6.86%) |
Mkt cap ! $126.2M |
Open | High | Low | Value | Volume |
51.0¢ | 55.0¢ | 51.0¢ | $167.8K | 316.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 317 | 53.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
54.5¢ | 4099 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 317 | 0.535 |
1 | 4000 | 0.530 |
2 | 35000 | 0.525 |
1 | 12500 | 0.520 |
1 | 25000 | 0.515 |
Price($) | Vol. | No. |
---|---|---|
0.545 | 45 | 1 |
0.550 | 5054 | 2 |
0.555 | 10000 | 1 |
0.560 | 6785 | 3 |
0.570 | 44444 | 1 |
Last trade - 15.59pm 06/09/2024 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |